H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 29,556 287 World Ranking 7366 National Ranking 4005

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

His main research concerns Surgery, Respiratory disease, Internal medicine, Pleural effusion and Pleural disease. Steven A. Sahn has researched Surgery in several fields, including Adverse effect, Incidence and Etiology. His Respiratory disease research incorporates elements of Effusion, Empyema, Pathology and Pneumothorax, Pleurodesis.

Steven A. Sahn interconnects Gastroenterology, Placebo and Bacteremia in the investigation of issues within Internal medicine. His Pleural disease study combines topics from a wide range of disciplines, such as Pleurisy, Atelectasis and Malignant pleural effusion. His study in Vital capacity is interdisciplinary in nature, drawing from both Pirfenidone and Nintedanib.

His most cited work include:

  • A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis (1848 citations)
  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. (1206 citations)
  • Management of Spontaneous Pneumothorax: An American College of Chest Physicians Delphi Consensus Statement (805 citations)

What are the main themes of his work throughout his whole career to date?

Steven A. Sahn focuses on Surgery, Pleural effusion, Internal medicine, Respiratory disease and Pathology. His Surgery research includes elements of Adverse effect and Incidence. His studies in Pleural effusion integrate themes in fields like Effusion and Empyema.

The various areas that Steven A. Sahn examines in his Internal medicine study include Gastroenterology and Cardiology. In his study, Mechanical ventilation is strongly linked to Intensive care medicine, which falls under the umbrella field of Respiratory disease. Steven A. Sahn works mostly in the field of Pathology, limiting it down to topics relating to Pleural fluid and, in certain cases, Acidosis.

He most often published in these fields:

  • Surgery (37.36%)
  • Pleural effusion (24.71%)
  • Internal medicine (24.71%)

What were the highlights of his more recent work (between 2010-2020)?

  • Internal medicine (24.71%)
  • Surgery (37.36%)
  • Idiopathic pulmonary fibrosis (8.62%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Surgery, Idiopathic pulmonary fibrosis, Pleural effusion and Pathology. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Physical therapy. Surgery is frequently linked to Pleural disease in his study.

His Idiopathic pulmonary fibrosis study integrates concerns from other disciplines, such as Placebo, Vital capacity, FEV1/FVC ratio and Minimal clinically important difference. He combines subjects such as Effusion and Empyema with his study of Pleural effusion. His Pathology research includes themes of Antibody and Pleural fluid.

Between 2010 and 2020, his most popular works were:

  • A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis (1848 citations)
  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. (1206 citations)
  • Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. (290 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

His primary areas of investigation include Internal medicine, Idiopathic pulmonary fibrosis, Surgery, FEV1/FVC ratio and Vital capacity. His Internal medicine research incorporates themes from Gastroenterology, Radiology and SCLEROSING AGENTS. His Gastroenterology study incorporates themes from Pleurisy and Pleural effusion.

His research integrates issues of Physical therapy and Randomized controlled trial in his study of Idiopathic pulmonary fibrosis. Surgery is closely attributed to Saline in his research. His work carried out in the field of Pirfenidone brings together such families of science as Placebo, Adverse effect and Clinical trial.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

Talmadge E. King;Williamson Z. Bradford;Socorro Castro-Bernardini;Elizabeth A. Fagan.
The New England Journal of Medicine (2014)

2535 Citations

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

Paul W Noble;Carlo Albera;Williamson Z Bradford;Ulrich Costabel.
The Lancet (2011)

1650 Citations

Management of Spontaneous Pneumothorax: An American College of Chest Physicians Delphi Consensus Statement

Michael H. Baumann;Charlie Strange;John E. Heffner;Richard Light.
Chest (2001)

1254 Citations

Medical and Surgical Treatment of Parapneumonic Effusions* An Evidence-Based Guideline

Gene L. Colice;Anne Curtis;Jean Deslauriers;John Heffner.
Chest (2000)

788 Citations

State of the art. The pleura.

Sahn Sa.
The American review of respiratory disease (1988)

703 Citations

Management of malignant pleural effusions.

V.B. Antony;R. Loddenkemper;P. Astoul;C. Boutin.
European Respiratory Journal (2001)

591 Citations

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Talmadge E King;Carlo Albera;Williamson Z Bradford;Ulrich Costabel.
The Lancet (2009)

551 Citations

Chemical Pleurodesis for Malignant Pleural Effusions

Pamela B. Walker-Renard;Leigh M. Vaughan;Steven A. Sahn.
Annals of Internal Medicine (1994)

528 Citations

Carcinomatous involvement of the pleura: an analysis of 96 patients.

Bart Chernow;Steven A. Sahn.
The American Journal of Medicine (1977)

526 Citations

Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006

Arun Gopi;Sethu M. Madhavan;Surendra K. Sharma;Steven A. Sahn.
Chest (2007)

459 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Steven A. Sahn

Richard W. Light

Richard W. Light

Vanderbilt University

Publications: 135

Toby M. Maher

Toby M. Maher

University of Southern California

Publications: 123

Luca Richeldi

Luca Richeldi

Catholic University of the Sacred Heart

Publications: 120

Athol U. Wells

Athol U. Wells

Imperial College London

Publications: 117

Vincent Cottin

Vincent Cottin

Claude Bernard University Lyon 1

Publications: 92

Harold R. Collard

Harold R. Collard

University of California, San Francisco

Publications: 86

Ganesh Raghu

Ganesh Raghu

University of Washington

Publications: 75

Kevin K. Brown

Kevin K. Brown

National Jewish Health

Publications: 72

Demosthenes Bouros

Demosthenes Bouros

National and Kapodistrian University of Athens

Publications: 62

Kevin R. Flaherty

Kevin R. Flaherty

University of Michigan–Ann Arbor

Publications: 59

Fernando J. Martinez

Fernando J. Martinez

Cornell University

Publications: 56

Jay H. Ryu

Jay H. Ryu

Mayo Clinic

Publications: 48

Ulrich Costabel

Ulrich Costabel

University of Duisburg-Essen

Publications: 45

Francis X. McCormack

Francis X. McCormack

University of Cincinnati

Publications: 37

Naftali Kaminski

Naftali Kaminski

Yale University

Publications: 37

Roland M. du Bois

Roland M. du Bois

Imperial College London

Publications: 35

Something went wrong. Please try again later.